T-O: 0.0 (08:59:00)
Last updated: 09:06
EPS | 2.52 sen |
Trailing PE (Sector Median: 23.8) | 22.6 |
PEG | 0.23 |
Altman Z | 1.8 |
Beaver | 0.131 |
Current Ratio | 2.3 |
Debt-Equity (DE) Ratio | 0.71 |
FCF Yield | 0.92 % |
Revenue QoQ | 60.51 % |
Revenue YoY | 64.34 % |
Profit QoQ | 101.48 % |
Profit YoY | 126.08 % |
Profit Margin (Sector Median: 10.3) | 13.93 % |
ROE (ROIC: 20.6) | 25.91 % |
Dividend Per Share (DPS) | 3.8 sen |
Dividend Yield (DY) | 6.67 % |
Discounted Cash Flow (DCF) 5% Growth | |
Discounted Cash Flow (DCF) 10% Growth | |
Relative Valuation | |
Average Analysts FV based on 3 rating(s) |
Graham Formula | |
Graham Number | |
Net Tangible Asset (NTA) | 0.19 | Consistent QR FV |
Forward PE FV Calculator | |
Latest Profit (adjusted) [M] | 2.59 |
Expected Profit (Next QR) [M] | |
Expected Profit (After QR above) [M] | |
Expected Profit (After QR above) [M] | |
Estimated Fair Value |
Growth/Risk Fair Value Calculator | |
Expected growth (%) | |
Estimated downside / risk (%) | |
Estimated New DCF Fair Value |
Contract/Award Contribution Calculator | |
Contract/Award Value (in Million) | |
Estimated Contribution to Stock Price | |
Estimated New DCF Fair Value |
Profit-Based Calculator | |
Expected Profit (M) | |
for Year | |
Estimated New DCF Fair Value |
Revenue-Based Calculator | |
Expected Revenue (M) | |
for Year | |
Estimated New DCF Fair Value |
Market Pricing | |
Expected Profit (M) | 106.92 |
Expected Revenue (M) | 1056.51 |
Expected Growth (%) | 44.0 |
TAN SRI DATO' TAN BOON HOCK reduced 1252000.0 units announced on 02 Apr 2021 at ~RM1.6
TAN SRI DATO' TAN BOON HOCK reduced 12565000.0 units announced on 01 Apr 2021 at ~RM1.77
TAN SRI DATO' TAN BOON HOCK added 106000.0 units announced on 12 Oct 2020 at ~RM0.74
TAN SRI DATO' TAN BOON HOCK added 250000.0 units announced on 09 Oct 2020 at ~RM0.75
Market Cap: 307 M.
Number of Shares: 540 M.
Adjusted Float: 38.4%.
Stock highly correlated with
MRDIY (88%)
CSCENIC (86%)
PARAGON (85%)
RALCO (85%)
OPTIMAX eye specialist centre has served over 210,000 patients since 1995. Having established itself as one of the most reputable eye care providers in South East Asia with a large clientele base, OPTIMAX provide a full spectrum of eye care treatments including lasik, cataract, glaucoma, dry eyes and others. Their clients comprise of local and international patients from Malaysia, Indonesia, Philippines, Singapore, Thailand, Australia, China, Hong Kong, Japan whom travelled to Malaysia to obtain their service.
Sectors: Healthcare, Health Care Providers
Code: 0222
Website: https://www.optimax2u.com/
Related Links: Bursa | Annual Report | Announcement
Symbol | Price | Ex.Price | Premium | Expiry |
---|---|---|---|---|
OPTIMAX-WA | 0.17 | 0.6 | 35.09% | 29-Dec-2026 |
Updated on 7-May-2021
Shareholder | Value (M) |
---|---|
Sena Healthcare Services Sdn. Bhd. | 44.95 |
Tan Sri Dato’ Tan Boon Hock | 41.07 |
Chung Soon Hee | 8.76 |
Chuah Kay Leong | 5.75 |
Soong Chee Keong | 5.7 |
Seah Ley Hong | 3.34 |
GA Skylight Berhad | 2.85 |
PMB Shariah Growth Fund | 2.53 |
Principal Islamic Malaysia Opportunities Fund | 2.19 |
Principal Small Cap Opportunities Fund | 1.47 |
Principal Malaysia Titans Fund | 1.09 |
Heng Sue Khe | 0.82 |
Principal Malaysia Titans Plus Fund | 0.78 |
Phillip Capital Management Sdn Bhd | 0.71 |
Tan Sing Chia | 0.59 |
Tan Sing Yee | 0.59 |
Principal Malaysia Enhanced Opportunities Fund | 0.56 |
Wong Yee Hui | 0.54 |
Tokio Marine Life Insurance Malaysia Bhd | 0.48 |
Lim Chin Siu | 0.43 |
Principal Malaysia Opportunities Fund | 0.42 |
Wong Tuck Lee | 0.41 |
Lee Boon Keat | 0.41 |
Gibraltar BSN Aggressive Fund | 0.4 |
Tan Chyi Boon | 0.38 |
Lee May Lin | 0.29 |
Wong Chee Kuan | 0.28 |
Young Swee Ting | 0.28 |
Yap Fei Yun | 0.27 |